{compound}: Research Intelligence Overview
Research Intelligence Overview {category} {mechanism} Further human research is needed.
Month: May 2026
The AICAR Paradox: Why the ‘Exercise Pill’ Fails to Cross the Rodent-to-Human Gap
The Myth and the Reality of AICAR Imagine swallowing a pill that delivers the metabolic benefits of …
Selank vs N-Acetyl Selank Amidate: Stability, BBB Penetration, and the Evidence Gap
The Evolution of Tuftsin: Framing the Selank Comparison Selank is a synthetic heptapeptide analog of Tuftsin, an …
The Piracetam Paradox: Why the Original Nootropic Still Lacks Healthy-User Data
The Giurgea Legacy: Defining the Nootropic Standard Piracetam set the template for every experimental compound that followed …
2025 Semax & N-Acetyl Semax Research Report: Data, Mechanisms, and the Human Translation Gap
Executive Summary: The 2025 Semax Evidence Snapshot Semax and N-Acetyl Semax are two mechanistically intriguing experimental compounds …
2025 Delta Sleep-Inducing Peptide (DSIP) Data Report: Analyzing the Gap Between Mechanisms and Human Outcomes
The state of DSIP research: 2025 headline findings Delta sleep-inducing peptide sits in a familiar position for …
The TB-500 Paradox: Why Mechanistic Theory Outpaces Human Evidence
Beyond the Hype: Defining the TB-500 and Thymosin Beta-4 Relationship TB-500 is not Thymosin Beta-4 — it …
The Peptide Blend Dilemma: Why Convenience Often Compromises Precision
The Rise of the Multi-Peptide Stack: Convenience vs. Control Pre-mixed peptide vials promise streamlined protocols, but convenience …
FOXO4-DRI and the Senolytic Frontier: Why the ‘Zombie Cell’ Peptide Isn’t Ready for Humans
The Senolytic Hypothesis: Beyond the ‘Zombie Cell’ Metaphor Cellular senescence is not cell death. It is something …
The CJC-1295 Paradox: Why Mechanism Doesn’t Always Equal Longevity
CJC-1295 Peptide: Beyond the Biohacking Hype Understanding the key mechanisms and differences of the CJC-1295 peptide is …